Related Experiment Video
Updated: Feb 19, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Therapeutic HPV vaccines
Gemma Hancock1, Karin Hellner2, Lucy Dorrell3
1Nuffield Department of Medicine, University of Oxford and Oxford NIHR Biomedical Research Centre, NDM Research Building, Old Road Campus, Headington, Oxford, UK.
Therapeutic human papillomavirus (HPV) vaccines aim to boost immune responses to clear existing infections and pre-cancerous lesions. This review explores developing strategies for treating HPV-associated cancers and conditions.
Area of Science:
- Oncology
- Immunology
- Virology
Background:
- High-risk human papillomavirus (HPV) is essential for cervical and anogenital cancers, causing over 250,000 deaths yearly.
- Current prophylactic HPV vaccines do not clear established infections or preinvasive lesions.
- Spontaneous regression of cervical dysplasia highlights the potential for immune-boosting therapies.
Purpose of the Study:
- To review therapeutic HPV vaccine strategies under development.
- To discuss approaches for treating HPV-associated lesions and malignancies.
Main Methods:
- Literature review of therapeutic HPV vaccine research.
- Analysis of strategies focusing on cell-mediated immunity.
Main Results:
- Therapeutic vaccines aim to generate cell-mediated immunity, distinct from prophylactic vaccines.
- Various therapeutic vaccine approaches are in development for HPV-associated conditions.
Conclusions:
- Therapeutic HPV vaccines offer a promising strategy to complement prophylactic vaccines.
- Boosting host immunity could significantly reduce HPV-related morbidity and mortality.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Vaccinations

